Mike D.
About Mike D.
Mike D. is a Senior Manager of Quality Assurance with extensive experience in the biotechnology and pharmaceutical industries. He has held various roles at companies such as AlloVir, Thermo Fisher Scientific, and Sanofi Genzyme, and holds degrees in Biomedical Engineering and Engineering Management.
Current Role at AlloVir
Mike D. serves as the Senior Manager of Quality Assurance at AlloVir. He has held this position since 2021, contributing to the organization's commitment to maintaining high-quality standards in its operations. His role involves overseeing quality assurance processes and ensuring compliance with industry regulations.
Previous Experience at Thermo Fisher Scientific
Before joining AlloVir, Mike D. worked at Thermo Fisher Scientific as a QA Client Alliance for a duration of 10 months from 2020 to 2021. His responsibilities included managing quality assurance initiatives and collaborating with clients to ensure their needs were met in compliance with quality standards.
Professional Background in Quality Assurance
Mike D. has extensive experience in quality assurance and project management. He worked at DPS Group Global as a CQV Project Manager from 2018 to 2020. Prior to that, he held the position of Validation Manager at Sanofi Genzyme for one year in 2017. His career began at Repligen Corporation, where he served as a Manufacturing Associate from 2007 to 2010.
Educational Background
Mike D. holds a Bachelor of Science in Biomedical Engineering from Boston University, where he studied from 2003 to 2007. He also earned a Master of Science in Engineering Management from Tufts University, completing his studies from 2016 to 2019. This educational foundation supports his expertise in quality assurance and project management.
Career Progression at Sanofi Genzyme
At Sanofi Genzyme, Mike D. held multiple roles, including Process Engineer III from 2015 to 2017 and Validation Manager in 2017. His experience in these positions contributed to his knowledge in quality assurance and validation processes within the biopharmaceutical industry.